Bio-Connect

Vunakizumab (Anti-CTLA-8 / IL-17a)

A2866
Selleck Chemicals
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Selleck Chemicals
  • Product Name
    Vunakizumab (Anti-CTLA-8 / IL-17a)
  • Delivery Days Customer
    9
  • Certification
    Research Use Only
  • Estimated Purity
    ...
  • Scientific Description
    Vunakizumab (Anti-CTLA-8 / IL-17a) is a recombinant human IgGkappa monoclonal antibody that targets interleukin-17A (IL-17A) and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis. MW: 146.28.
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203